NCT06437938View on ClinicalTrials.gov

The Effects of Dietary Supplements on Glycemic Control, Body Composition and Hepatic Fat Content in People With Prediabetes

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 25, 2024

Primary Completion Date

May 1, 2025

Study Completion Date

August 31, 2025

Conditions
PreDiabetes
Interventions
DIETARY_SUPPLEMENT

Dietary supplement A: Wasabi leaf powder (product of BIOGENA GmbH & Co KG)

To be taken according to the information in the study protocol/patient information leaflet.

DIETARY_SUPPLEMENT

Dietary supplement B: Berberin Phytoactive Gold (product of BIOGENA GmbH & Co KG)

To be taken according to the information in the study protocol/patient information leaflet.

DIETARY_SUPPLEMENT

Dietary supplement C: DiaPhyt® Formula 3.0 (product of BIOGENA GmbH & Co KG)

To be taken according to the information in the study protocol/patient information leaflet.

OTHER

Placebo group 1: Placebo capsules corresponding to DiaPhyt® Formula 3.0/Berberin Phytoactive Gold

To be taken according to the information in the study protocol/patient information leaflet.

OTHER

Placebo group 2: Placebo powder corresponding to Wasabi leaf powder

To be taken according to the information in the study protocol/patient information leaflet.

Trial Locations (1)

1090

RECRUITING

Medical University of Vienna, Vienna

All Listed Sponsors
collaborator

BIOGENA GmbH

UNKNOWN

lead

Medical University of Vienna

OTHER